Lv5
1154 积分 2023-06-02 加入
Chemical Evolution of Antibody–Drug Conjugates Focused on Linker Design and Conjugation Strategies in Hematology
17天前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
17天前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
17天前
已完结
Precision chemical synthesis of PEGylated IGF2 for potent and selective lysosomal degradation of transmembrane proteins
18天前
已完结
Modular Assembly of Bioconjugates Enabled by a Pyridine‐Based Chemoselective Sequential Conjugation Platform
18天前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
22天前
已完结
Design, development, and therapeutic applications of PARP-1 selective inhibitors
22天前
已完结
Research progress and development strategies of antibody-oligonucleotide conjugates
24天前
已完结
Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors
24天前
已完结
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
24天前
已完结
皖公网安备34019202002308
